-
1دورية أكاديمية
المساهمون: Shanu Modi, Cristina Saura, Toshinari Yamashita, Yeon Hee Park, Sung-Bae Kim, Kenji Tamura, Fabrice Andre, Hiroji Iwata, Yoshinori Ito, Junji Tsurutani, Joohyuk Sohn, Neelima Denduluri, Christophe Perrin, Kenjiro Aogi, Eriko Tokunaga, Seock-Ah Im, Keun Seok Lee, Sara A Hurvitz, Javier Cortes, Caleb Lee, Shuquan Chen, Lin Zhang, Javad Shahidi, Antoine Yver, Ian Krop, Sohn, Joo Hyuk
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Breast Neoplasms / drug therapy, Breast Neoplasms / mortality, Breast Neoplasms / pathology, Camptothecin / administration & dosage, Camptothecin / adverse effects, Camptothecin / analogs & derivatives, Consolidation Chemotherapy, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Diseases, Interstitial / chemically induced, Middle Aged, Progression-Free Survival, Receptor, ErbB-2 / analysis, ErbB-2 / antagonists & inhibitors, Trastuzumab
العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2022-03982; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190269Test; T9992020494; NEW ENGLAND JOURNAL OF MEDICINE, Vol.382(7) : 610-621, 2020-02
الإتاحة: https://doi.org/10.1056/NEJMoa1914510Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190269Test -
2دورية أكاديمية
المساهمون: Hope S Rugo, Aditya Bardia, Sara M Tolaney, Carlos Arteaga, Javier Cortes, Joohyuk Sohn, Frederik Marmé, Quan Hong, Rosemary J Delaney, Amir Hafeez, Fabrice André, Peter Schmid, Sohn, Joo Hyuk
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Humanized / therapeutic use, Antigens, Neoplasm, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Immunological / therapeutic use, Biomarkers, Tumor, Breast Neoplasms / drug therapy, Breast Neoplasms / etiology, Breast Neoplasms / metabolism, Breast Neoplasms / pathology, Camptothecin / administration & dosage, Camptothecin / adverse effects, Camptothecin / analogs & derivatives, Camptothecin / therapeutic use, Cell Adhesion Molecules / antagonists & inhibitors, Drug Resistance, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / therapeutic use, Molecular Targeted Therapy, Neoplasm Metastasis
العلاقة: FUTURE ONCOLOGY; J00914; OAK-2021-05739; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185005Test; T999202314; FUTURE ONCOLOGY, Vol.16(12) : 705-715, 2020-04
الإتاحة: https://doi.org/10.2217/fon-2020-0163Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185005Test -
3دورية أكاديمية
المساهمون: Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda, Choi, Hye Jin
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / immunology, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / immunology, Biliary Tract Neoplasms / mortality, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / genetics, Male, Middle Aged, Progression-Free Survival, Receptor, Transforming Growth Factor-beta Type II / genetics, Recombinant Fusion Proteins / administration & dosage, Recombinant Fusion Proteins / adverse effects, Recombinant Fusion Proteins / genetics, Signal Transduction / drug effects, Signal Transduction / immunology, Transforming Growth Factor beta / antagonists & inhibitors, Transforming Growth Factor beta / metabolism, Young Adult, gastrointestinal neoplasms, immunotherapy
العلاقة: JOURNAL FOR IMMUNOTHERAPY OF CANCER; J03617; OAK-2021-02662; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test; T202007285; JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol.8(1) : e000564, 2020-05
الإتاحة: https://doi.org/10.1136/jitc-2020-000564Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test